Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2012 4
2013 5
2014 3
2015 2
2016 2
2018 3
2019 1
2020 3
2021 1
2023 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
John NA, Solanky BS, De Angelis F, Parker RA, Weir CJ, Stutters J, Carrasco FP, Schneider T, Doshi A, Calvi A, Williams T, Plantone D, Monteverdi A, MacManus D, Marshall I, Barkhof F, Gandini Wheeler-Kingshott CAM, Chataway J; MS‐SMART Investigators. John NA, et al. Among authors: solanky bs. J Magn Reson Imaging. 2024 Jun;59(6):2192-2201. doi: 10.1002/jmri.29017. Epub 2023 Oct 3. J Magn Reson Imaging. 2024. PMID: 37787109 Clinical Trial.
A Risk Score for Predicting Multiple Sclerosis.
Dobson R, Ramagopalan S, Topping J, Smith P, Solanky B, Schmierer K, Chard D, Giovannoni G. Dobson R, et al. Among authors: solanky b. PLoS One. 2016 Nov 1;11(11):e0164992. doi: 10.1371/journal.pone.0164992. eCollection 2016. PLoS One. 2016. PMID: 27802296 Free PMC article.
Challenges and Perspectives of Quantitative Functional Sodium Imaging (fNaI).
Gandini Wheeler-Kingshott CAM, Riemer F, Palesi F, Ricciardi A, Castellazzi G, Golay X, Prados F, Solanky B, D'Angelo EU. Gandini Wheeler-Kingshott CAM, et al. Among authors: solanky b. Front Neurosci. 2018 Nov 9;12:810. doi: 10.3389/fnins.2018.00810. eCollection 2018. Front Neurosci. 2018. PMID: 30473659 Free PMC article.
Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT.
De Angelis F, Connick P, Parker RA, Plantone D, Doshi A, John N, Stutters J, MacManus D, Prados F, Marshall I, Solanky B, Samson RS, Barkhof F, Ourselin S, Braisher M, Ross M, Cranswick G, Pavitt SH, Gnanapavan S, Giovannoni G, Wheeler-Kingshott CAMG, Hawkins C, Sharrack B, Bastow R, Weir CJ, Stallard N, Chandran S, Chataway J. De Angelis F, et al. Among authors: solanky b. Southampton (UK): NIHR Journals Library; 2020 May. Southampton (UK): NIHR Journals Library; 2020 May. PMID: 32453521 Free Books & Documents. Review.
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study.
Solanky BS, John NA, DeAngelis F, Stutters J, Prados F, Schneider T, Parker RA, Weir CJ, Monteverdi A, Plantone D, Doshi A, MacManus D, Marshall I, Barkhof F, Gandini Wheeler-Kingshott CAM, Chataway J; MS-SMART Investigators. Solanky BS, et al. AJNR Am J Neuroradiol. 2020 Dec;41(12):2209-2218. doi: 10.3174/ajnr.A6809. Epub 2020 Nov 5. AJNR Am J Neuroradiol. 2020. PMID: 33154071 Free PMC article. Clinical Trial.
Patterns of inflammation, microstructural alterations, and sodium accumulation define multiple sclerosis subtypes after 15 years from onset.
Ricciardi A, Grussu F, Kanber B, Prados F, Yiannakas MC, Solanky BS, Riemer F, Golay X, Brownlee W, Ciccarelli O, Alexander DC, Gandini Wheeler-Kingshott CAM. Ricciardi A, et al. Among authors: solanky bs. Front Neuroinform. 2023 Mar 23;17:1060511. doi: 10.3389/fninf.2023.1060511. eCollection 2023. Front Neuroinform. 2023. PMID: 37035717 Free PMC article.
27 results